Test ID: FMENC
Meningoencephalitis Comprehensive Panel (CSF)
Reference Values
Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.
California Encephalitis Virus Antibody Panel, IFA (CSF)
Reference Range: IgG <1:4
IgM <1:4
NOTE: Specimens positive for arbovirus antibody are CDC reportable.
Please contact your local public health agency.
Diagnosis of infections of the central nervous system can be
accomplished by demonstrating the presence of intrathecally-
produced specific antibody. However, interpreting results is
complicated by low antibody levels found in CSF, passive
transfer of antibody from blood, and contamination via bloody
taps. The interpretation of CSF results must consider CSF-serum
antibody ratios to the infectious agent.
Eastern Equine Encephalitis Virus Antibody, IFA (CSF)
Reference Range: IgG <1:4
IgM <1:4
NOTE: Specimens positive for arbovirus antibody are CDC reportable.
Please contact your local public health agency.
Diagnosis of infections of the central nervous system can be
accomplished by demonstrating the presence of intrathecally-
produced specific antibody. However, interpreting results is
complicated by low antibody levels found in CSF, passive
transfer of antibody from blood, and contamination via bloody
taps. The interpretation of CSF results must consider CSF-serum
antibody ratios to the infectious agent.
St. Louis Encephalitis Virus Antibody, IFA (CSF)
Reference Range: IgG <1:4
IgM <1:4
NOTE: Specimens positive for arbovirus antibody are CDC reportable.
Please contact your local public health agency.
Diagnosis of infections of the central nervous system can be
accomplished by demonstrating the presence of intrathecally-
produced specific antibody. However, interpreting results is
complicated by low antibody levels found in CSF, passive
transfer of antibody from blood, and contamination via bloody
taps. The interpretation of CSF results must consider CSF-serum
antibody ratios to the infectious agent.
Western Equine Encephalitis IgG and IgM Pnl, IFA (CSF)
Reference Range: IgG <1:4
IgM <1:4
NOTE: Specimens positive for arbovirus antibody are CDC reportable.
Please contact your local public health agency.
Diagnosis of infections of the central nervous system can be
accomplished by demonstrating the presence of intrathecally-
produced specific antibody. However, interpreting results is
complicated by low antibody levels found in CSF, passive
transfer of antibody from blood, and contamination via bloody
taps. The interpretation of CSF results must consider CSF-serum
antibody ratios to the infectious agent.
Lymphocytic Choriomeningitis (LCM) Virus Ab, IFA (CSF)
Reference Range: IgG <1:1
IgM <1:1
Interpretive Criteria:
<1:1 Antibody Not Detected
> or = 1:1 Antibody Detected
Diagnosis of infections of the central nervous system can be
accomplished by demonstrating the presence of intrathecally-
produced specific antibody. However, interpreting results is
complicated by low antibody levels found in CSF, passive
transfer of antibody from blood, and contamination via bloody
taps.
This assay was developed and its performance
characteristics determined by Focus Diagnostics. It has
not been cleared or approved by the U.S. Food and Drug
Administration. The FDA has determined that such
clearance or approval is not necessary. Performance
characteristics refer to the analytical performance of the
test.
Herpes Simplex Virus 1/2 (IgG) Type-Specific Antibodies, CSF
Reference Range: < or = 1.00
Interpretive Criteria:
< or = 1.00 Antibody Not Detected
>1.00 Antibody Detected
Detection of HSV type-specific IgG in CSF may indicate central
nervous system (CNS) infection by that HSV type. However,
interpretation of results may be complicated by a number of
factors, including low antibody levels found in CSF, passive transfer
of antibody across the blood-brain barrier, and serum contamination
of CSF during CSF collection. PCR detection of type-specific HSV
DNA in CSF is the preferred method for identifying HSV CNS infections.
Herpes Simplex Virus (HSV) 1/2 IgM Antibody, IFA (CSF)
Reference Range: <1:1
Interpretive Criteria
<1:1 Antibody Not Detected
> or = 1:1 Antibody Detected
The IFA procedure for measuring IgM antibodies to HSV 1 and
HSV 2 detects both type-common and type-specific HSV
antibodies. Thus, elevated titers to both HSV 1 and HSV 2 may
represent crossreactive HSV antibodies rather than exposure to
both HSV 1 and HSV 2.
The intrathecal synthesis of HSV antibody is most accurately
measured by performing the Antibody Index for CNS Infection.
Diagnosis of central nervous system infections can be
accomplished by demonstrating the presence of intrathecally-
produced specific antibody. Interpreting results may be
complicated by low antibody levels found in CSF, passive
transfer of antibody from blood, and contamination via
bloody taps. The interpretation of CSF results must consider CSF-
serum antibody ratios to the infectious agent.
This assay was developed and its performance characteristics have
been determined by Focus Diagnostics. It has not been cleared or
approved by the U.S. Food and Drug Administration. The FDA has
determined that such clearance or approval is not necessary.
Performance characteristics refer to the analytical performance of the test.
Adenovirus Antibody, CF (CSF)
REFERENCE RANGE: <1:1
INTERPRETIVE CRITERIA:
<1:1 Antibody Not Detected
> or = 1:1 Antibody Detected
Diagnosis of infections of the central nervous system is
accomplished by demonstrating the presence of intrathecally-
produced specific antibody. Interpretation of results may be
complicated by low antibody levels found in CSF, passive
transfer of antibody from blood, and contamination via bloody taps.
The interpretation of CSF results must consider CSF-serum
antibody ratios to the infectious agent.
This test was developed and its performance characteristics have
been determined by Focus Diagnostics. Performance characteristics
refer to the analytical performance of the test.
Influenza Type A and B Antibodies, CSF
REFERENCE RANGE: <1:1
INTERPRETIVE CRITERIA:
<1:1 Antibody Not Detected
> or = 1:1 Antibody Detected
Diagnosis of infections of the central nervous system is
accomplished by demonstrating the presence of intrathecally-
produced specific antibody. Interpretation of results may be
complicated by low antibody levels found in CSF, passive
transfer of antibody from blood, and contamination via bloody
taps. The interpretation of CSF results must consider CSF-serum
antibody ratios to the infectious agent.
This test was developed and its performance characteristics have
been determined by Focus Diagnostics. Performance characteristics
refer to the analytical performance of the test.
Measles (Rubeola) IgG and IgM Antibody Panel, IFA (CSF)
Reference Range: IgG <1:64
IgM <1:1
Diagnosis of central nervous system infections can be
accomplished by demonstrating the presence of intrathecally-
produced specific antibody. Interpreting results may be
complicated by low antibody levels found in CSF, passive
transfer of antibody from blood, and contamination via bloody
taps. The interpretation of CSF results must consider CSF-serum
antibody ratios to the infectious agent.
This assay was developed and its performance characteristics
have been determined by Focus Diagnostics. It has not been
cleared or approved by the U.S. Food and Drug Administration.
The FDA has determined that such clearance or approval is
not necessary. Performance characteristics refer to the analytical
performance of the test.
Mumps Antibody Panel, IFA (CSF)
Reference Range: IgG <1:8
IgM <1:1
Diagnosis of infections of the central nervous system is
accomplished by demonstrating the presence of intrathecally-
produced specific antibody. Interpretation of results may be
complicated by low antibody levels found in CSF, passive
transfer of antibody from blood, and contamination via bloody
taps. The interpretation of CSF results must consider CSF-serum
antibody ratios to the infectious agent.
This assay was developed and its performance characteristics
have been determined by Focus Diagnostics. It has not been
cleared or approved by the U.S. Food and Drug Administration.
The FDA has determined that such clearance or approval is
not necessary. Performance characteristics refer to the analytical
performance of the test.
Varicella-Zoster Virus Antibody, CSF
Reference Range: <1:1
Interpretive Criteria:
<1:1 Antibody Not Detected
> or = 1:1 Antibody Detected
Diagnosis of infections of the central nervous system is
accomplished by demonstrating the presence of intrathecally-
produced specific antibody. Interpretation of results may be
complicated by low antibody levels found in CSF, passive
transfer of antibody from blood, and contamination via bloody
taps. The interpretation of CSF results must consider CSF-serum
antibody ratios to the infectious agent.
This test was developed and its performance characteristics have been
determined by Focus Diagnostics. Performance characteristics refer to
the analytical performance of the test.
Coxsackie A Antibodies, CSF
Reference Range: <1:1
Interpretive Criteria:
<1:1 Antibody Not Detected
> or = 1:1 Antibody Detected
Diagnosis of infections of the central nervous system is
accomplished by demonstrating the presence of intrathecally-
produced specific antibody. Interpretation of results may be
complicated by low antibody levels found in CSF, passive
transfer of antibody from blood, and contamination via bloody
taps.The interpretation of CSF results must consider CSF-serum
antibody ratios to the infectious agent.
This test was developed and its performance characteristics have been
determined by Focus Diagnostics. Performance characteristics refer to
the analytical performance of the test.
Coxsackie B (1-6) Antibodies, CSF
Reference Range: <1:1
Interpretive Criteria:
<1:1 Antibody Not Detected
> or = 1:1 Antibody Detected
Diagnosis of infections of the central nervous system is
accomplished by demonstrating the presence of intrathecally-
produced specific antibody. Interpretation of results may be
complicated by low antibody levels found in CSF, passive
transfer of antibody from blood, and contamination via bloody
taps. The interpretation of CSF results must consider CSF-serum
antibody ratios to the infectious agent.
This test was developed and its performance characteristics have been
determined by Focus Diagnostics. Performance characteristics refer to
the analytical performance of the test.
Echovirus Antibodies, CSF
Reference Range: <1:1
Interpretive Criteria:
<1:1 Antibody Not Detected
> or = 1:1 Antibody Detected
Diagnosis of infections of the central nervous system is
accomplished by demonstrating the presence of intrathecally-
produced specific antibody. Interpretation of results may be
complicated by low antibody levels found in CSF, passive
transfer of antibody from blood, and contamination via bloody
taps. The interpretation of CSF results must consider CSF-serum
antibody ratios to the infectious agent.
Cytomegalovirus (CMV) IgG Antibody, ELISA (CSF)
Reference Range: <0.80
Interpretive Criteria:
<0.80 Antibody not detected
0.80 – 0.99 Equivocal
> or = 1.00 Antibody detected
Diagnosis of infections of the central nervous system is
accomplished by demonstrating the presence of intrathecally-
produced specific antibody. Interpretation of results may be
complicated by low antibody levels found in CSF, passive transfer
passive transfer of antibody from blood, and contamination via
bloody taps. The interpretation of CSF results must consider CSF-
serum antibody ratios to the infectious agent. The intrathecal
synthesis of CMV antibody is most accurately measured by
performing the Antibody Index for CNS Infection.
Cytomegalovirus (CMV) IgM Antibody, ELISA (CSF)
Reference Range: <0.90
Interpretive Criteria:
<0.90 Antibody not detected
0.90 - 1.09 Equivocal
> or = 1.10 Antibody detected
Diagnosis of infections of the central nervous system is
accomplished by demonstrating the presence of intrathecally-
produced specific antibody. Interpretation of results may be
complicated by low antibody levels found in CSF, passive
transfer of antibody from blood, and contamination via bloody
taps. The interpretation of CSF results must consider CSF-serum
antibody ratios to the infectious agent. The intrathecal synthesis
of CMV antibody is most accurately measured by performing the
Antibody Index for CNS Infection.
West Nile Virus Antibody Panel, ELISA (CSF)
Reference Range:
IgG <1.30
IgM <0.90
Interpretive Criteria:
IgG:
<1.30 Antibody not detected
1.30 - 1.50 Equivocal
>1.50 Antibody detected
IgM:
<0.90 Antibody not detected
0.90 - 1.10 Equivocal
>1.10 Antibody detected
In the very early stages of acute West Nile Virus (WNV) infection, IgM
may be detectable in CSF before it becomes detectable in serum. Antibodies
induced by other flavivirus infections (e.g., Dengue, St. Louis Encephalitis)
may show crossreactivity with WNV; thus, antibody detection using this panel
is not diagnostically conclusive for WNV infection. Final diagnosis should be
based on confirmatory assays, such as the plaque reduction neutralization test.
WNV antibody results for CSF should be interpreted with caution. Complicating
factors include low antibody levels found in CSF, passive transfer of antibody
from blood, and contamination via bloody taps.
Test Performed by: Focus Diagnostics, Inc.
5785 Corporate Ave.
Cypress, CA 90630


